Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis.
OBJECTIVE
To assess the potential of using vaccination with Porphyromonas gingivalis or Fusobacterium nucleatum, in modulating local subcutaneous inflammatory response and alveolar bone loss following coinfection with both bacteria.


METHODS
Mice were immunized against either P. gingivalis or F. nucleatum. The cytokine response to mixed infection with P. gingivalis and F. nucleatum was evaluated using the subcutaneous chamber model. The alveolar bone loss induced by oral mixed infection was evaluated by micro-CT using the experimental periodontitis model. Serum levels of specific antibodies were determined by ELISA.


RESULTS
Vaccination with either bacterium produced a specific humoral response before infection. Animals immunized against either bacteria following a mixed infection with P. gingivalis and F. nucleatum, showed decreased TNFalpha (but not IL-1beta) levels as compared with non-immunized animals. However, the vaccination did not change the level of mixed infection-induced alveolar bone loss when compared with non-immunized animals. Six weeks following the oral mixed infection, specific antibody titres remained high. Furthermore, specific antibodies against the non-immunized bacterium were present at high levels.


CONCLUSIONS
While vaccination produced specific antibodies and suppressed the inflammatory response, it failed to prevent or reduce the progression of experimental periodontitis induced by mixed infection with P. gingivalis and F. nucleatum.
Polak
David
D
Departments of Periodontology, The Hebrew University-Hadassah Medical Center, Jerusalem, Israel. polak@cc.huji.ac.il
Wilensky
Asaf
A
Shapira
Lior
L
Weiss
Ervin I
EI
Houri-Haddad
Yael
Y
D016301:Alveolar Bone Loss / Q000382:microbiology / Q000517:prevention & control; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001428:Bacterial Vaccines; D016866:Bacteroidaceae Infections / Q000276:immunology* / Q000517:prevention & control; D018450:Disease Progression; D005260:Female; D005674:Fusobacterium Infections / Q000276:immunology* / Q000517:prevention & control; D016967:Fusobacterium nucleatum / Q000276:immunology*; D007114:Immunization; D007279:Injections, Subcutaneous; D053583:Interleukin-1beta / Q000097:blood; D051379:Mice; D008807:Mice, Inbred BALB C; D010518:Periodontitis / Q000382:microbiology* / Q000517:prevention & control; D016966:Porphyromonas gingivalis / Q000276:immunology*; D013047:Specific Pathogen-Free Organisms; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D014611:Vaccination; D015164:Vaccines, Inactivated; D055114:X-Ray Microtomography
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D053583:Interleukin-1beta; D014409:Tumor Necrosis Factor-alpha; D015164:Vaccines, Inactivated